Literature DB >> 8760059

Dephosphorylation of activated protein kinase C contributes to downregulation by bryostatin.

H W Lee1, L Smith, G R Pettit, J Bingham Smith.   

Abstract

We show that bryostatin 1 (Bryo) rapidly produces an inactive, incompetent 76-kDa form of protein kinase C-alpha (PKC-alpha) in the LLC-MK2 line of renal epithelial cells. Bryo, like phorbol 12-myristate 13-acetate (PMA), acutely activated PKC, as indicated by autophosphorylation and translocation of PKC-alpha, the predominant PMA-sensitive isoform expressed by the cells. Bryo concomitantly increased the 32P labeling of 80-kDa PKC-alpha by autophosphorylation and produced a 76-kDa form of PKC-alpha that lacked detectable 32P. The 76-kDa form was in the particulate rather than the cytosolic fraction, which suggests that it was produced from activated kinase. Alkaline phosphatase treatment of immunoprecipitated PKC-alpha converted the 80-kDa form to 76 kDa, but it had no effect on the mobility of the 76-kDa form, suggesting that it was not phosphorylated. Pulse-chase labeling of PKC-alpha with [35S]Met/Cys indicated that there is a precursor-product relationship between the 80- and 76-kDa forms, respectively. Inhibition of protein synthesis had no effect on the production of 76-kDa PKC-alpha by Bryo. PMA also produced 76-kDa PKC-alpha but was less potent and efficacious than Bryo. Bryo produced a more rapid loss of 80-kDa PKC-alpha protein and total Ca(2+)- and phospholipid-dependent PKC activity than PMA. The 76-kDa form is inactive and incompetent because it lacked detectable 32P under conditions that strongly autophosphorylated the 80-kDa form. We suggest that dephosphorylation predisposes PKC to proteolysis, and greater production of the 76-kDa form explains the more efficient downregulation of the kinase by Bryo vs. PMA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760059     DOI: 10.1152/ajpcell.1996.271.1.C304

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  19 in total

Review 1.  Multiple pathways control protein kinase C phosphorylation.

Authors:  D B Parekh; W Ziegler; P J Parker
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

2.  Peptidyl-prolyl isomerase Pin1 controls down-regulation of conventional protein kinase C isozymes.

Authors:  Hilde Abrahamsen; Audrey K O'Neill; Natarajan Kannan; Nicole Kruse; Susan S Taylor; Patricia A Jennings; Alexandra C Newton
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

Review 3.  The life and death of protein kinase C.

Authors:  Christine M Gould; Alexandra C Newton
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

4.  Regulation of protein kinase C delta downregulation by protein kinase C epsilon and mammalian target of rapamycin complex 2.

Authors:  Alakananda Basu; Savitha Sridharan; Shalini Persaud
Journal:  Cell Signal       Date:  2009-07-23       Impact factor: 4.315

5.  Multisite dephosphorylation and desensitization of conventional protein kinase C isotypes.

Authors:  G Hansra; P Garcia-Paramio; C Prevostel; R D Whelan; F Bornancin; P J Parker
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

6.  Modulation of Target Antigen Density Improves CAR T-cell Functionality and Persistence.

Authors:  Sneha Ramakrishna; Steven L Highfill; Zachary Walsh; Sang M Nguyen; Haiyan Lei; Jack F Shern; Haiying Qin; Ira L Kraft; Maryalice Stetler-Stevenson; Constance M Yuan; Jennifer D Hwang; Yang Feng; Zhongyu Zhu; Dimiter Dimitrov; Nirali N Shah; Terry J Fry
Journal:  Clin Cancer Res       Date:  2019-05-20       Impact factor: 12.531

Review 7.  Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders.

Authors:  H C Ringvold; R A Khalil
Journal:  Adv Pharmacol       Date:  2016-07-18

8.  Heat shock proteins regulate activation-induced proteasomal degradation of the mature phosphorylated form of protein kinase C.

Authors:  Michelle A Lum; Gregor M Balaburski; Maureen E Murphy; Adrian R Black; Jennifer D Black
Journal:  J Biol Chem       Date:  2013-07-30       Impact factor: 5.157

Review 9.  Signaling inhibitors in the treatment of prostate cancer.

Authors:  Gary R Hudes
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850

10.  Downregulation of protein kinase C-alpha enhances intracellular survival of Mycobacteria: role of PknG.

Authors:  Shivendra K Chaurasiya; Kishore K Srivastava
Journal:  BMC Microbiol       Date:  2009-12-24       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.